Nov 19, 2026
OpenAI Opens Labs to 4 Independent Evaluators After Rogue Agent Incidents
OpenAI has signed agreements with Apollo Research, METR, Transluce, and Goodfire to get independent access to its labs, models, and training data. The move follows rogue agent incidents and a California lawsuit citing 80 cases of 'loss of control.'
Nov 19, 2026
OpenAI GPT-6.2 Launch Gets Scathing Reviews as Testers Call It 'Unusable'
OpenAI released GPT-6.2 Astra and Sol this week but early testers are eviscerating the models, with one calling them 'essentially unusable.' The disappointing launch comes just days before Anthropic's historic IPO, creating an unexpected contrast between the two AI rivals.
Nov 19, 2026
Anthropic IPO Priced at $83 Per Share in Largest-Ever Tech Debut
Anthropic priced its blockbuster IPO at $83 per share late Wednesday, raising $81.3 billion and valuing the Claude maker at roughly $1.5 trillion. Trading begins Thursday on Nasdaq under ticker ANT, making it the largest public market debut in history — and a referendum on whether Wall Street still believes in the AI boom.
Related News
Oct 29, 2026
Anthropic’s expanded science credits follow different research-access routes
Anthropic’s October 28 expansion distributes Claude credits through funders, inside research institutions and directly to specific initiatives. Researchers need to identify which route can support their project.
Oct 28, 2026
Anthropic outlines six drug-development partnerships and in-house Mithril work
Anthropic’s October 27 update separates external research collaborations from Mithril Medicine work now inside the company. It describes early research involvement, not an acquisition closing date or a clinical result.
Oct 28, 2026
Anthropic joins phData funding for Claude implementation and enterprise data services
phData disclosed new backing from Gryphon and Anthropic without an amount or valuation. The plan expands Claude implementation and data services, rather than launching a new model or establishing customer results.